頁面路徑選單
- 首頁
- 市場技術報告
- 電子零件 & 半導體
- 感測器
- 報告資訊
Biosensors Market by Application, Product, Technology & Geography - Analysis & Forecast to 2020
出 版 商：MarketsandMarkets
出版日期：2015/01/14
頁 數：193頁
文件格式：PDF
價 格：
USD 4,650 (Single-User License)
USD 5,650 (Multi-User License)
USD 7,150 (Global-User License)
USD 5,650 (Multi-User License)
USD 7,150 (Global-User License)
The biosensor is a device which is used for detecting, recording, and transmitting information related to any physiological changes or the presence of various chemicals or biological materials in the environment. In other words, we can say that it is an analytical device, which converts the biological response into electrical signals. The biosensors technology is now being used for the development of various biosensor applications, such as the medical, healthcare, biodefense, environment monitoring, and food industries.
This report is based on an extensive research study of the biosensors market and aims at identifying the entire market and all its sub-segments through the extensively detailed classifications. The demand for the biosensors is expecting a significant growth and importance among the industry players across various verticals. APAC is projected to be the fastest growing markets due to the high adoption of medical diagnostics and testing devices.
This report is focused on giving a bird’s eye-view of the industry with regard to the biosensors market, with qualitative analysis at each and every aspect of the classification done on the basis of products, technologies, applications, and geographies. The report provides a forecast of the growth of the biosensors market from 2014 to 2020. A complete competitive landscape of the current market is analyzed from the market share analysis and rankings of current key players; all the other details of the key players are discussed in their company profiles. The competitive information provided in this report includes market shares of the leading companies in the biosensors ecosystem, key developments, core strategies deployed by various players, mergers and acquisitions, new product developments, collaborations, and joint ventures of key manufacturers along with their company profiles.
The report also discusses the future of the global market with road-maps, upcoming technologies, markets, and applications with respect to the biosensors market. The key players in this industry include F. Hoffmann-La Roche Ltd. (Switzerland), LifeScan Inc. (U.S.), Bayer Healthcare AG (Germany), Abbott Point-of-Care Inc. (U.S.), Medtronic (U.S.), Siemens Healthcare (Germany), and others.
This report is based on an extensive research study of the biosensors market and aims at identifying the entire market and all its sub-segments through the extensively detailed classifications. The demand for the biosensors is expecting a significant growth and importance among the industry players across various verticals. APAC is projected to be the fastest growing markets due to the high adoption of medical diagnostics and testing devices.
This report is focused on giving a bird’s eye-view of the industry with regard to the biosensors market, with qualitative analysis at each and every aspect of the classification done on the basis of products, technologies, applications, and geographies. The report provides a forecast of the growth of the biosensors market from 2014 to 2020. A complete competitive landscape of the current market is analyzed from the market share analysis and rankings of current key players; all the other details of the key players are discussed in their company profiles. The competitive information provided in this report includes market shares of the leading companies in the biosensors ecosystem, key developments, core strategies deployed by various players, mergers and acquisitions, new product developments, collaborations, and joint ventures of key manufacturers along with their company profiles.
The report also discusses the future of the global market with road-maps, upcoming technologies, markets, and applications with respect to the biosensors market. The key players in this industry include F. Hoffmann-La Roche Ltd. (Switzerland), LifeScan Inc. (U.S.), Bayer Healthcare AG (Germany), Abbott Point-of-Care Inc. (U.S.), Medtronic (U.S.), Siemens Healthcare (Germany), and others.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 PACKAGE SIZE
1.6 LIMITATIONS
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primaries
2.2 FACTOR ANALYSIS
2.2.1 INTRODUCTION
2.2.2 DEMAND SIDE ANALYSIS
2.2.2.1 Growth in the Healthcare Expenditure
2.2.2.2 Progression Toward Healthcare Decentralization
2.2.2.3 Prevalence of Diabetes Continues to Increase
2.2.2.4 Rapid Growth of the Aging Population
2.2.2.5 Related Market Analysis: Transducers Market
2.2.2.6 Poor Customer Perception
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS AND LIMITATIONS
2.5.1 ASSUMPTIONS
2.5.2 LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ADOPTION OF BIOSENSORS IN VARIOUS CLINICAL AND NON-CLINICAL APPLICATIONS IS DRIVING THE BIOSENSORS MARKET
4.1 POINT-OF-CARE DOMINATED THE OVERALL BIOSENSORS MARKET, 2013
4.2 KEY FACTORS BEHIND THE GROWTH OF THE BIOSENSORS MARKET IN APAC- UPGRADE OF THE EXISTING HEALTHCARE SYSTEMS & LARGE POPULATION
4.3 TECHNOLOGICAL ADVANCEMENTS & INCREASED HEALTHCARE COST LIKELY TO DRIVE THE BIOSENSORS MARKET IN THE U.S.
4.4 NORTH AMERICA EXPECTED TO CONTINUE TO DOMINATE THE MARKET FOR BIOSENSOR APPLICATIONS
4.5 BIOSENSORS MARKET: DEVELOPED VS. DEVELOPING NATIONS
4.6 WEARABLE BIOSENSORS LIKELY TO IMPACT THE GLOBAL HEALTHCARE INDUSTRY
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 EVOLUTION OF THE BIOSENSORS TECHNOLOGY
5.3 MARKET SEGMENTATION
5.3.1 BIOSENSORS MARKET, BY APPLICATION
5.3.2 BIOSENSORS MARKET, BY TECHNOLOGY
5.3.3 BIOSENSORS MARKET SEGMENTATION: BY PRODUCT
5.3.4 BIOSENSORS MARKET SEGMENTATION: BY GEOGRAPHY
5.4 MARKET DYNAMICS
5.4.1 DRIVERS
5.4.1.1 Emergence of Nanotechnology/Nanobiosensors
5.4.1.2 Significant technological advancements over the last few years
5.4.1.3 Glucose monitoring in diabetics patients
5.4.1.4 Increase in the demand for home based POC devices
5.4.2 RESTRAINTS
5.4.2.1 Slow rate of commercialization
5.4.2.2 High cost involved in the research and development
5.4.2.3 Reluctance toward the adoption of new treatment practices
5.4.3 OPPORTUNITIES
5.4.3.1 Emerging market in the developing countries
5.4.3.2 Use of biosensors for non-medical applications, such as- the food industry, environmental monitoring, and biodefense
5.4.4 CHALLENGES
5.4.4.1 Government regulations—long certification & approval cycles
5.4.4.2 Pricing pressure in the point-of-care market
5.4.5 BURNING ISSUE
5.4.5.1 High cost devices limit the growth of the biosensors market
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.2.1 VALUE CHAIN ANALYSIS: BIOSENSORS
6.3 INDUSTRY TRENDS
6.4 EMERGING TRENDS
6.4.1 OPEN, CONNECTED HEALTHCARE PLATFORMS
6.4.2 PERSONALIZED MEDICINE —A MEDICAL MODEL
6.4.3 LAB ON A CHIP
6.5 BIOSENSORS PLATFORM AND BUSINESS MODEL
6.6 PORTER’S FIVE FORCES ANALYSIS
6.6.1 THREATS OF NEW ENTRANTS
6.6.2 THREATS OF SUBSTITUTES
6.6.3 BARGAINING POWER OF SUPPLIERS
6.6.4 BARGAINING POWER OF BUYERS
6.6.5 INTENSITY OF RIVALRY
6.7 PEST ANALYSIS
6.7.1 POLITICAL FACTORS
6.7.2 ECONOMIC FACTORS
6.7.3 SOCIAL FACTORS
6.7.4 TECHNOLOGICAL FACTORS
6.8 STRATEGIC BENCHMARKING
6.8.1 TECHNOLOGY INTEGRATION & PRODUCT ENHANCEMENT
6.8.2 ENTRY INTO TUMOR/CANCER TESTING MARKET
7 BIOSENSORS MARKET ANALYSIS, BY APPLICATION
7.1 INTRODUCTION
7.2 POINT-OF-CARE
7.2.1 POINT-OF-CARE APPLICATION, BY GEOGRAPHY
7.2.2 POINT-OF-CARE APPLICATION, BY PRODUCT
7.2.3 GLUCOSE MONITORING
7.2.4 CARDIAC MARKERS
7.2.5 INFECTIOUS DISEASES TESTING KITS
7.2.6 COAGULATION MONITORING KITS
7.2.7 PREGNANCY AND FERTILITY TESTING KITS
7.2.8 BLOOD GAS AND ELECTROLYTE
7.2.9 TUMOR/CANCER MARKERS
7.2.10 URINALYSIS TESTING KITS
7.2.11 CHOLESTEROL TEST
7.2.12 OTHERS
7.3 HOME DIAGNOSTICS
7.3.1 HOME DIAGNOSTICS APPLICATION, BY GEOGRAPHY
7.3.2 HOME DIAGNOSTICS APPLICATION, BY PRODUCT
7.4 RESEARCH LABS
7.4.1 RESEARCH LAB APPLICATION, BY GEOGRAPHY
7.4.2 RESEARCH LAB APPLICATION, BY PRODUCT
7.5 BIODEFENSE
7.5.1 BIODEFENSE APPLICATION, BY GEOGRAPHY
7.5.2 BIODEFENSE APPLICATION, BY PRODUCT
7.6 ENVIRONMENTAL MONITORING
7.6.1 ENVIRONMENTAL MONITORING APPLICATION, BY GEOGRAPHY
7.6.2 ENVIRONMENTAL MONITORING, BY PRODUCT
7.7 FOOD INDUSTRY
8 BIOSENSORS MARKET ANALYSIS, BY TECHNOLOGY
8.1 INTRODUCTION
8.1.1 COMPARATIVE ANALYSIS OF BIOSENSING TECHNOLOGIES (BIOTRANSDUCERS)
8.2 ELECTROCHEMICAL BIOSENSORS
8.2.1 ADVANTAGES OF ELECTROCHEMICAL BIOSENSORS
8.2.2 MAJOR COMPANIES
8.2.3 CONDUCTOMETRIC BIOSENSORS
8.2.4 AMPEROMETRIC BIOSENSORS
8.2.5 POTENTIOMETRIC BIOSENSORS
8.2.6 OTHERS
8.3 PIEZOELECTRIC BIOSENSORS
8.4 OPTICAL BIOSENSORS
8.5 THERMAL BIOSENSORS
8.6 OTHERS
9 BIOSENSORS MARKET ANALYSIS, BY PRODUCT
9.1 INTRODUCTION
9.2 WEARABLE BIOSENSORS
9.2.1 WRIST-WEAR
9.2.2 EYE-WEAR
9.2.3 FOOT-WEAR
9.2.4 NECK-WEAR
9.2.5 BODY-WEAR
9.2.6 OTHERS
9.3 NON-WEARABLE BIOSENSORS
10 BIOSENSORS MARKET ANALYSIS, BY GEOGRAPHY
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.3 EUROPE
10.4 APAC
10.5 ROW
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS, BIOSENSORS MARKET
11.3 COMPETITIVE SITUATION AND TRENDS
11.3.1 NEW PRODUCT LAUNCHES, 2011-2014
11.3.2 ACQUISITION
11.3.3 PARTNERSHIPS AND AGREEMENTS
11.3.4 EXPANSIONS
11.3.5 AWARDS AND RECOGNITION
12 COMPANY PROFILES
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 ABBOTT POINT OF CARE, INC.
12.2 ACON LABORATORIES, INC.
12.3 BAYER AG
12.4 F. HOFFMAN LA-ROCHE LTD.
12.5 LIFESCAN, INC.
12.6 LIFESENSORS INC.
12.7 MEDTRONIC INC.
12.8 NOVA BIOMEDICAL CORPORATION
12.9 PHARMACO-KINESIS CORPORATION
12.10 SIEMENS AG
12.11 UNIVERSAL BIOSENSORS
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 PACKAGE SIZE
1.6 LIMITATIONS
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primaries
2.2 FACTOR ANALYSIS
2.2.1 INTRODUCTION
2.2.2 DEMAND SIDE ANALYSIS
2.2.2.1 Growth in the Healthcare Expenditure
2.2.2.2 Progression Toward Healthcare Decentralization
2.2.2.3 Prevalence of Diabetes Continues to Increase
2.2.2.4 Rapid Growth of the Aging Population
2.2.2.5 Related Market Analysis: Transducers Market
2.2.2.6 Poor Customer Perception
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS AND LIMITATIONS
2.5.1 ASSUMPTIONS
2.5.2 LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ADOPTION OF BIOSENSORS IN VARIOUS CLINICAL AND NON-CLINICAL APPLICATIONS IS DRIVING THE BIOSENSORS MARKET
4.1 POINT-OF-CARE DOMINATED THE OVERALL BIOSENSORS MARKET, 2013
4.2 KEY FACTORS BEHIND THE GROWTH OF THE BIOSENSORS MARKET IN APAC- UPGRADE OF THE EXISTING HEALTHCARE SYSTEMS & LARGE POPULATION
4.3 TECHNOLOGICAL ADVANCEMENTS & INCREASED HEALTHCARE COST LIKELY TO DRIVE THE BIOSENSORS MARKET IN THE U.S.
4.4 NORTH AMERICA EXPECTED TO CONTINUE TO DOMINATE THE MARKET FOR BIOSENSOR APPLICATIONS
4.5 BIOSENSORS MARKET: DEVELOPED VS. DEVELOPING NATIONS
4.6 WEARABLE BIOSENSORS LIKELY TO IMPACT THE GLOBAL HEALTHCARE INDUSTRY
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 EVOLUTION OF THE BIOSENSORS TECHNOLOGY
5.3 MARKET SEGMENTATION
5.3.1 BIOSENSORS MARKET, BY APPLICATION
5.3.2 BIOSENSORS MARKET, BY TECHNOLOGY
5.3.3 BIOSENSORS MARKET SEGMENTATION: BY PRODUCT
5.3.4 BIOSENSORS MARKET SEGMENTATION: BY GEOGRAPHY
5.4 MARKET DYNAMICS
5.4.1 DRIVERS
5.4.1.1 Emergence of Nanotechnology/Nanobiosensors
5.4.1.2 Significant technological advancements over the last few years
5.4.1.3 Glucose monitoring in diabetics patients
5.4.1.4 Increase in the demand for home based POC devices
5.4.2 RESTRAINTS
5.4.2.1 Slow rate of commercialization
5.4.2.2 High cost involved in the research and development
5.4.2.3 Reluctance toward the adoption of new treatment practices
5.4.3 OPPORTUNITIES
5.4.3.1 Emerging market in the developing countries
5.4.3.2 Use of biosensors for non-medical applications, such as- the food industry, environmental monitoring, and biodefense
5.4.4 CHALLENGES
5.4.4.1 Government regulations—long certification & approval cycles
5.4.4.2 Pricing pressure in the point-of-care market
5.4.5 BURNING ISSUE
5.4.5.1 High cost devices limit the growth of the biosensors market
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.2.1 VALUE CHAIN ANALYSIS: BIOSENSORS
6.3 INDUSTRY TRENDS
6.4 EMERGING TRENDS
6.4.1 OPEN, CONNECTED HEALTHCARE PLATFORMS
6.4.2 PERSONALIZED MEDICINE —A MEDICAL MODEL
6.4.3 LAB ON A CHIP
6.5 BIOSENSORS PLATFORM AND BUSINESS MODEL
6.6 PORTER’S FIVE FORCES ANALYSIS
6.6.1 THREATS OF NEW ENTRANTS
6.6.2 THREATS OF SUBSTITUTES
6.6.3 BARGAINING POWER OF SUPPLIERS
6.6.4 BARGAINING POWER OF BUYERS
6.6.5 INTENSITY OF RIVALRY
6.7 PEST ANALYSIS
6.7.1 POLITICAL FACTORS
6.7.2 ECONOMIC FACTORS
6.7.3 SOCIAL FACTORS
6.7.4 TECHNOLOGICAL FACTORS
6.8 STRATEGIC BENCHMARKING
6.8.1 TECHNOLOGY INTEGRATION & PRODUCT ENHANCEMENT
6.8.2 ENTRY INTO TUMOR/CANCER TESTING MARKET
7 BIOSENSORS MARKET ANALYSIS, BY APPLICATION
7.1 INTRODUCTION
7.2 POINT-OF-CARE
7.2.1 POINT-OF-CARE APPLICATION, BY GEOGRAPHY
7.2.2 POINT-OF-CARE APPLICATION, BY PRODUCT
7.2.3 GLUCOSE MONITORING
7.2.4 CARDIAC MARKERS
7.2.5 INFECTIOUS DISEASES TESTING KITS
7.2.6 COAGULATION MONITORING KITS
7.2.7 PREGNANCY AND FERTILITY TESTING KITS
7.2.8 BLOOD GAS AND ELECTROLYTE
7.2.9 TUMOR/CANCER MARKERS
7.2.10 URINALYSIS TESTING KITS
7.2.11 CHOLESTEROL TEST
7.2.12 OTHERS
7.3 HOME DIAGNOSTICS
7.3.1 HOME DIAGNOSTICS APPLICATION, BY GEOGRAPHY
7.3.2 HOME DIAGNOSTICS APPLICATION, BY PRODUCT
7.4 RESEARCH LABS
7.4.1 RESEARCH LAB APPLICATION, BY GEOGRAPHY
7.4.2 RESEARCH LAB APPLICATION, BY PRODUCT
7.5 BIODEFENSE
7.5.1 BIODEFENSE APPLICATION, BY GEOGRAPHY
7.5.2 BIODEFENSE APPLICATION, BY PRODUCT
7.6 ENVIRONMENTAL MONITORING
7.6.1 ENVIRONMENTAL MONITORING APPLICATION, BY GEOGRAPHY
7.6.2 ENVIRONMENTAL MONITORING, BY PRODUCT
7.7 FOOD INDUSTRY
8 BIOSENSORS MARKET ANALYSIS, BY TECHNOLOGY
8.1 INTRODUCTION
8.1.1 COMPARATIVE ANALYSIS OF BIOSENSING TECHNOLOGIES (BIOTRANSDUCERS)
8.2 ELECTROCHEMICAL BIOSENSORS
8.2.1 ADVANTAGES OF ELECTROCHEMICAL BIOSENSORS
8.2.2 MAJOR COMPANIES
8.2.3 CONDUCTOMETRIC BIOSENSORS
8.2.4 AMPEROMETRIC BIOSENSORS
8.2.5 POTENTIOMETRIC BIOSENSORS
8.2.6 OTHERS
8.3 PIEZOELECTRIC BIOSENSORS
8.4 OPTICAL BIOSENSORS
8.5 THERMAL BIOSENSORS
8.6 OTHERS
9 BIOSENSORS MARKET ANALYSIS, BY PRODUCT
9.1 INTRODUCTION
9.2 WEARABLE BIOSENSORS
9.2.1 WRIST-WEAR
9.2.2 EYE-WEAR
9.2.3 FOOT-WEAR
9.2.4 NECK-WEAR
9.2.5 BODY-WEAR
9.2.6 OTHERS
9.3 NON-WEARABLE BIOSENSORS
10 BIOSENSORS MARKET ANALYSIS, BY GEOGRAPHY
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.3 EUROPE
10.4 APAC
10.5 ROW
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS, BIOSENSORS MARKET
11.3 COMPETITIVE SITUATION AND TRENDS
11.3.1 NEW PRODUCT LAUNCHES, 2011-2014
11.3.2 ACQUISITION
11.3.3 PARTNERSHIPS AND AGREEMENTS
11.3.4 EXPANSIONS
11.3.5 AWARDS AND RECOGNITION
12 COMPANY PROFILES
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 ABBOTT POINT OF CARE, INC.
12.2 ACON LABORATORIES, INC.
12.3 BAYER AG
12.4 F. HOFFMAN LA-ROCHE LTD.
12.5 LIFESCAN, INC.
12.6 LIFESENSORS INC.
12.7 MEDTRONIC INC.
12.8 NOVA BIOMEDICAL CORPORATION
12.9 PHARMACO-KINESIS CORPORATION
12.10 SIEMENS AG
12.11 UNIVERSAL BIOSENSORS
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
